Low-dose aspirin for CVD and colorectal cancer prevention no longer recommendedU.S. statement shows an aspirin a day won’t keep the doctor away, but Canadian doc says still needed for secondary prevention. Antifibrinolytic reduces non-cardiac surgical bleedingPOISE-3 results showed drug performed better than placebo. How to diagnose and treat long COVID cardiac symptoms What to do when patients come in with cardiac symptoms following COVID infection. Novel drug proving beneficial in HCM patients Study shows sustained effects, improved function, health status Aspirin beneficial to hospitalized COVID-19 patients Even though many getting Aspirin were more likely to have other risk factors. Which anticoagulant is the best to prevent recurrent VTE? Study compares four common anticoagulants for long-term safety, effectiveness. Heart of gold: researchers use gold spray to restore heart function in mouse model Innovative spray-on technology could be used to repair heart following myocardial infarction. Long-term cardiovascular risks are substantial in COVID-19 survivors Survivors of COVID-19 are at increased risk of adverse cardiovascular outcomes even if they were not hospitalized during the acute phase of infection. Spironolactone not associated with a significant increase in cancer risk Systematic review and meta-analysis finds no substantial increased risk of cancer with spironolactone, and a decreased risk of prostate cancer. Sudden death in athletes reduced three-fold with bystander training Paris-based study shows training programs work—Canadian experts push for bystander education at a national level. First Previous 26 27 28 29 30 Next Last
